Sarah Palmer
Sarah Palmer
Unknown affiliation
Verified email at sydney.edu.au
TitleCited byYear
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Q Yu, R König, S Pillai, K Chiles, M Kearney, S Palmer, D Richman, ...
Nature structural & molecular biology 11 (5), 435-442, 2004
6452004
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
S Palmer, F Maldarelli, A Wiegand, B Bernstein, GJ Hanna, SC Brun, ...
Proceedings of the National Academy of Sciences 105 (10), 3879-3884, 2008
6132008
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman, IB Hogue, S Palmer, C Jennings, CA Spina, A Wiegand, ...
The Lancet 366 (9485), 549-555, 2005
5972005
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer, AP Wiegand, F Maldarelli, H Bazmi, JAM Mican, M Polis, ...
Journal of clinical microbiology 41 (10), 4531-4536, 2003
5772003
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
MJ Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ...
Nature medicine 16 (4), 460, 2010
5472010
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
DE Kaufmann, DG Kavanagh, F Pereyra, JJ Zaunders, EW Mackey, ...
Nature immunology 8 (11), 1246-1254, 2007
5252007
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis
S Palmer, M Kearney, F Maldarelli, EK Halvas, CJ Bixby, H Bazmi, D Rock, ...
Journal of clinical microbiology 43 (1), 406-413, 2005
5082005
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control
SA Migueles, CM Osborne, C Royce, AA Compton, RP Joshi, KA Weeks, ...
Immunity 29 (6), 1009-1021, 2008
4942008
Towards an HIV cure: a global scientific strategy
SG Deeks, B Autran, B Berkhout, M Benkirane, S Cairns, N Chomont, ...
Nature reviews Immunology 12 (8), 607, 2012
4772012
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
JB Dinoso, SY Kim, AM Wiegand, SE Palmer, SJ Gange, L Cranmer, ...
Proceedings of the National Academy of Sciences 106 (23), 9403-9408, 2009
4472009
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies
S Eriksson, EH Graf, V Dahl, MC Strain, SA Yukl, ES Lysenko, RJ Bosch, ...
PLoS pathogens 9 (2), 2013
4322013
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical …
TA Rasmussen, M Tolstrup, CR Brinkmann, R Olesen, C Erikstrup, ...
The lancet HIV 1 (1), e13-e21, 2014
3662014
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
F Maldarelli, S Palmer, MS King, A Wiegand, MA Polis, JA Mican, ...
PLoS pathogens 3 (4), 2007
3232007
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy
JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ...
PLoS pathogens 10 (11), 2014
3122014
The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial
RT Gandhi, L Zheng, RJ Bosch, ES Chan, DM Margolis, S Read, ...
PLoS medicine 7 (8), 2010
2912010
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient
SA Yukl, E Boritz, M Busch, C Bentsen, TW Chun, D Douek, E Eisele, ...
PLoS pathogens 9 (5), 2013
2392013
International AIDS Society global scientific strategy: towards an HIV cure 2016
SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ...
Nature medicine 22 (8), 839, 2016
2252016
Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients
RW Shafer, MA Winters, S Palmer, TC Merigan
Annals of Internal Medicine 128 (11), 906-911, 1998
2211998
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy
D McMahon, J Jones, A Wiegand, SJ Gange, M Kearney, S Palmer, ...
Clinical infectious diseases 50 (6), 912-919, 2010
2172010
A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
H Hatano, TL Hayes, V Dahl, E Sinclair, TH Lee, R Hoh, H Lampiris, ...
The Journal of infectious diseases 203 (7), 960-968, 2011
2012011
The system can't perform the operation now. Try again later.
Articles 1–20